期刊
INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 132, 期 2, 页码 286-288出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2007.08.066
关键词
Asymmetric dimethylarginine; Coronary circulation; Angiotensin-converting enzyme inhibitor; Diabetes mellitus
资金
- Ministry of Health, Labour and Welfare, Japan [14C-3]
Measurements of serum asymmetric dimethylarginine ( ADMA), an endogenous nitric oxide synthase inhibitor, and coronary flow velocity reserve (CFVR) using transthoracic Doppler echocardiography were performed at baseline and after 4 weeks of temocapril therapy ( 2 mg/day) in 18 patients with type 2 diabetes. Although blood pressure, fasting blood sugar and lipid profiles remained unchanged, serum ADMA concentrations decreased significantly (0.51 +/- 0.08 to 0.46 +/- 0.07 mu mol/1, p < 0.01) and CFVR increased significantly (2.78 +/- 0.36 to 3.35 +/- 0.46, p < 0.001) after the treatment. Moreover, a strong correlation was observed between the difference of ADMA and that of CFVR (r=- 0.80, p < 0.001). Temocapril reduced serum ADMA concentrations, improved CFVR beyond its blood pressure lowering effect. Our results suggest that decrease in ADMA by temocapril treatment is related to improvement of coronary circulation as determined by CFVR in patients with type 2 diabetes. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据